Your browser doesn't support javascript.
loading
Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial.
Asherie, Nathalie; Kfir-Erenfeld, Shlomit; Avni, Batia; Assayag, Miri; Dubnikov, Tatyana; Zalcman, Nomi; Lebel, Eyal; Zimran, Eran; Shaulov, Adir; Pick, Marjorie; Cohen, Yael; Avivi, Irit; Cohen, Cyrille; Gatt, Moshe E; Grisariu, Sigal; Stepensky, Polina.
Afiliação
  • Asherie N; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem. nathaliea@hadassah.org.il.
  • Kfir-Erenfeld S; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem.
  • Avni B; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem.
  • Assayag M; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem.
  • Dubnikov T; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem.
  • Zalcman N; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem.
  • Lebel E; Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem.
  • Zimran E; Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem.
  • Shaulov A; Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem.
  • Pick M; Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem.
  • Cohen Y; Department of Hematology, Aviv Medical Center, Sackler faculty of medicine, Aviv University.
  • Avivi I; Department of Hematology, Aviv Medical Center, Sackler faculty of medicine, Aviv University.
  • Cohen C; Laboratory of Tumor Immunology and Immunotherapy, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan 52900-02, Israel.
  • Gatt ME; Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem.
  • Grisariu S; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem.
  • Stepensky P; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem. polina@hadassah.org.il.
Haematologica ; 108(7): 1827-1839, 2023 Jul 01.
Article em En | MEDLINE | ID: mdl-36200421
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article